GlassScriptPhysician profile
Allison Eaton
NPI 1124222963
$1,098.45
in general payments reported to CMS, 2019-2025
26 companies · $87.46 in 2025
The $87.46 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $26.88 · 2021: $15.57 · 2022: $125 · 2023: $431 · 2024: $249 · 2025: $87.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $767.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emmaus Medical, INC. | $179.83 | 2023 | Endari |
| Abbvie INC. | $153.16 | 2019-2025 | Liletta, Lo Loestrin Fe, Orilissa |
| Sumitomo Pharma America, INC. | $123.69 | 2023-2024 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $73.65 | 2023-2024 | Slynd |
| Astellas Pharma US INC | $70.22 | 2023-2024 | Veozah |
| C. R. Bard, INC. & Subsidiaries | $58.26 | 2024 | |
| Sage Therapeutics, LLC | $35.25 | 2025 | Zurzuvae |
| Pfizer INC. | $33.86 | 2019-2021 | |
| Astellas Pharma Global Development | $33.37 | 2024 | Veozah |
| Organon LLC | $31.14 | 2024 | |
| Duchesnay USA Incorporated | $28.23 | 2019 | |
| Daiichi Sankyo INC. | $26.67 | 2023 | Injectafer |
| Conmed Corporation | $24.92 | 2024 | |
| Millicent US INC | $23.55 | 2025 | Femlyv |
| Merck Sharp & Dohme LLC | $23.19 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $21.71 | 2024 | Myosure Tissue Removal Device |
| Myovant Sciences INC. | $21.67 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.57 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.16 | 2022 | |
| Lilly USA, LLC | $16.60 | 2019 | |
| Therapeuticsmd, INC. | $16.55 | 2019 | |
| Roche Diagnostics Corporation | $15.76 | 2019 | |
| Mayne Pharma Commercial LLC | $14.39 | 2025 | |
| Coopersurgical, INC. | $12.44 | 2022 | |
| Minerva Surgical, INC | $12.41 | 2022 | |
| Covidien LP | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Eaton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.